What happens when one healthcare company owns the transaction that is responsible for drug pricing transparency nationwide? Parts 1 and 2 of this series explore questionable prescription drug pricing ...
The settlement comes after a federal court determined that Surescripts holds a 95% 'supershare' for e-prescribing services. The Federal Trade Commission announced Thursday that it has reached a ...
ARLINGTON, Va.--(BUSINESS WIRE)--Surescripts®, the nation's leading health information network, has now expanded its innovative Sig IQ technology, first introduced for Medication History in 2022, to E ...
Electronic prescription company Surescripts has released a new service that gives pharmacists access to information on out-of-pocket prescription costs and drug alternatives. The service, called ...
Through a new partnership, all users of eClinicalWorks software will have access to Surescripts' electronic prior authorization service. Surescripts' CompletEPA solution will be integrated into the ...
The addition will include approximately 250,000 prescribers nationwide, according to a news release. NextGen will use CompletEPA, Surescripts’ software, to audit prior authorizations for prescriptions ...
ARLINGTON, Va.--(BUSINESS WIRE)--In 2021, Surescripts delivered its enhanced Medication History services to providers nationwide, with a 21% increase in the use of Medication History during patient ...
BLUE BELL, Pa., June 29, 2021 /PRNewswire/ — UBC, a late stage research and patient support services organization, announced a partnership with Surescripts, the nation’s leading health information ...
Surescripts, the nation’s leading health information network, has released a new data report, dubbed "Clinician Perspectives & Prescribing Patterns Reveal Opportunities for Care Team Evolution," ...
Surescripts, and Clear, an identity platform specializing in security, released a joint case study, Surescripts and Clear: Enhancing Provider Access & Security, highlighting how their collaboration is ...
A federal judge has rejected Surescripts' motion to dismiss an antitrust lawsuit from the Federal Trade Commission, a blow to the e-prescribing giant as the curtains rise on what's likely to be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results